Silvestris, E., de Pergola, G., Rosania, R., & Loverro, G
Those include high blood pressure, high cholesterol, sleep apnea and joint pain
Most experimental patches use microarray technologythousands of tiny needles that penetrate the outer skin layerbut this still requires regular replacement and carries infection risks similar to injections
Why Eli Lilly Emerged as the GLP-1 Market Leader Eli Lillys rise to the top of the GLP-1 field is due to a combination of blockbuster sales, smart R&D strategy, and aggressive expansion all timed with the soaring demand for new weight-loss therapies
Below is a timeline of confirmed developments and expected events in 2026 based on manufacturer announcements, FDA filings, and major media reporting
[26] [27] Non-fasting samples are acceptable for routine monitoring